Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

A 2-item food security instrument captures similar mortality risk information as instruments with more items among adults in the US.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

HealthDay News — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions ...

Cervical artery dissection incidence increased from 2005 to 2019, with admissions particularly high in older, Black, and Hispanic populations.

Researchers have found that patients with stage B heart failure characteristics and type 2 diabetes have impaired functional capacity.

The table below is a review of notable updates that occurred in March 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.